Published in Healthcare Finance, Tax and Law Weekly, August 22nd, 2007
For the six months ended June 30, 2007, GenVec's net loss was $10.2 million or ($0.14) per share, compared to a net loss of $8.2 million or ($0.13) per share for the six months ended June 30, 2006. Included in the net loss for the first six months of 2007 was stock-based compensation of $1,121,000 as compared to $583,000 for the same prior year period. GenVec ended the second quarter of 2007 with $29.4 million in cash and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.